ICOS and COVID-19: To investigate the activation status (HLA-DR, ICOS, and PD-1) of TFH cells, PBMCs from 16 COVID-19 convalescents, 17 vaccinees, and 19 healthy controls were stimulated with BSA or spike protein (Supplementary Table 4).